0002001011-24-000019.txt : 20240216 0002001011-24-000019.hdr.sgml : 20240216 20240216201038 ACCESSION NUMBER: 0002001011-24-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240215 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reardon Andrew CENTRAL INDEX KEY: 0001950232 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 24650317 MAIL ADDRESS: STREET 1: C/O LIGAND PHARMACEUTICALS INCORPORATED STREET 2: 3911 SORRENTO VALLEY BLVD, SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-02-15 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001950232 Reardon Andrew 3911 SORRENTO VALLEY, SUITE 110 SAN DIEGO CA 92121 0 1 0 0 CHIEF LEGAL OFFICER & 0 Common Stock 2024-02-15 4 F 0 593 74.65 D 14997 D Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. /s/ Andrew Reardon 2024-02-16